127 related articles for article (PubMed ID: 34994319)
1. Procalcitonin as a Prognostic Factor in Patients with COVID-19 in Southwestern Iran.
Abadi MSS; Taheri E; Raesi A; Arjmand MH; Kheirii S; Shahinfard N; Habibi Z
Infect Disord Drug Targets; 2022; 22(3):e070122200097. PubMed ID: 34994319
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin levels in COVID-19 patients.
Hu R; Han C; Pei S; Yin M; Chen X
Int J Antimicrob Agents; 2020 Aug; 56(2):106051. PubMed ID: 32534186
[TBL] [Abstract][Full Text] [Related]
3. The role of procalcitonin in predicting risk of mechanical ventilation and mortality among moderate to severe COVID-19 patients.
Twe CW; Khoo DKY; Law KB; Ahmad Nordin NSB; Sathasivan S; Lim KC; Atikah SK; Syed Badaruddin SNAB; Chidambaram SK
BMC Infect Dis; 2022 Apr; 22(1):378. PubMed ID: 35428273
[TBL] [Abstract][Full Text] [Related]
4. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
5. The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Heidari-Beni F; Vahedian-Azimi A; Shojaei S; Rahimi-Bashar F; Shahriary A; Johnston TP; Sahebkar A
Adv Exp Med Biol; 2021; 1321():277-286. PubMed ID: 33656733
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
[TBL] [Abstract][Full Text] [Related]
8. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
10. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.
Atallah NJ; Warren HM; Roberts MB; Elshaboury RH; Bidell MR; Gandhi RG; Adamsick M; Ibrahim MK; Sood R; Bou Zein Eddine S; Cobler-Lichter MJ; Alexander NJ; Timmer KD; Atallah CJ; Viens AL; Panossian VS; Scherer AK; Proctor T; Smartt S; Letourneau AR; Paras ML; Johannes S; Wiemer J; Mansour MK
PLoS One; 2022; 17(1):e0262342. PubMed ID: 35025929
[TBL] [Abstract][Full Text] [Related]
11. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
Lugito NPH
Curr Res Transl Med; 2021 May; 69(2):103289. PubMed ID: 33845428
[TBL] [Abstract][Full Text] [Related]
12. Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: A retrospective study from a single center.
Chen X; Yang Y; Huang M; Liu L; Zhang X; Xu J; Geng S; Han B; Xiao J; Wan Y
J Med Virol; 2020 Sep; 92(9):1572-1579. PubMed ID: 32237148
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin as a predictor of severity and mortality in a cohort of patients hospitalised with COVID-19.
Ahmed S; Ahmed ZA; Rashid NH; Mansoor M; Siddiqui I; Jafri L
Malays J Pathol; 2021 Dec; 43(3):375-380. PubMed ID: 34958058
[TBL] [Abstract][Full Text] [Related]
14. Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies.
Shen Y; Cheng C; Zheng X; Jin Y; Duan G; Chen M; Chen S
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34207689
[No Abstract] [Full Text] [Related]
15. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
Vazzana N; Dipaola F; Ognibene S
Acta Clin Belg; 2022 Apr; 77(2):268-272. PubMed ID: 32966166
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis.
Zare ME; Wang Y; Nasir Kansestani A; Almasi A; Zhang J
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):557-569. PubMed ID: 33463126
[TBL] [Abstract][Full Text] [Related]
17. The role of C-reactive protein, procalcitonin, interleukin-6 and neutrophil / lymphocyte ratio as a laboratory biomarker in COVID-19.
Al-Juboori RSF; Al-Bayaa YJ
Egypt J Immunol; 2024 Apr; 31(2):93-101. PubMed ID: 38615266
[TBL] [Abstract][Full Text] [Related]
18. Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients.
Tang J; Lin J; Zhang E; Zhong M; Luo Y; Fu Y; Yang Y
Medicine (Baltimore); 2021 Jun; 100(22):e26131. PubMed ID: 34087864
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
López-Ayala P; Alcaraz-Serna A; Valls Carbó A; Cuadrado Cenzual MÁ; Torrejón Martínez MJ; López Picado A; Martínez Valero C; Miranda JD; Díaz Del Arco C; Cozar López G; Suárez-Cadenas MDM; Jerez Fernández P; Angós B; Rodríguez Adrada E; Cardassay E; Del Toro E; Chaparro D; Montalvo Moraleda MT; Espejo Paeres C; García Briñón MÁ; Hernández Martín-Romo V; Ortega L; Fernández Pérez C; Martínez-Novillo M; González Armengol JJ; González Del Castillo J; Mueller CE; Martín-Sánchez FJ;
Emergencias; 2022 Apr; 34(2):119-127. PubMed ID: 35275462
[TBL] [Abstract][Full Text] [Related]
20. Serum procalcitonin level is independently associated with mechanical ventilation and case-fatality in hospitalized COVID-19-positive US veterans-A potential marker for disease severity.
Jeyapalina S; Wei G; Stoddard GJ; Sudduth JD; Lundquist M; Huntsman M; Marquez JL; Agarwal JP
PLoS One; 2023; 18(4):e0284520. PubMed ID: 37068086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
